HIKMA PHARMACEUTICALS PLC ORD S (HIK.L) Financials
HIK.L Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 367.3 billion | 194.0 billion |
| 2023-06-30 | 365.9 billion | 191.5 billion |
| 2023-03-31 | ? | ? |
| 2022-12-31 | 369.5 billion | 192.0 billion |
HIK.L Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-06-30 | 10.9 billion | 792.1 million |
| 2023-03-31 | ? | ? |
| 2022-12-31 | 6.3 billion | 454.5 million |
HIK.L Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 2.3 billion |
| 2023-06-30 | 10.4 billion |
| 2023-03-31 | 5.3 billion |
| 2022-12-31 | 4.8 billion |
HIK.L Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 16.1 billion | - | 5.2 billion |
| 2023-06-30 | 23.3 billion | - | 5.5 billion |
| 2023-03-31 | - | - | - |
| 2022-12-31 | 24.1 billion | - | 5.8 billion |
HIK.L Shares Outstanding
HIK.L Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | - | - |
| 2023-06-30 | 6.7 billion | 5.1 billion | - | - |
| 2023-03-31 | 3.4 billion | - | - | - |
| 2022-12-31 | 4.6 billion | 6.2 billion | 10.5 billion | 10.6 billion |
HIK.L Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | - | - |
| 2023-06-30 | 113.0 billion | 56.4 billion |
| 2023-03-31 | - | - |
| 2022-12-31 | 107.8 billion | 54.7 billion |
HIK.L
Price: £19.38
Dividend Yield: 0.00%
Forward Dividend Yield: 4.87%
Payout Ratio: 17735.85%
Dividend Per Share: 94.00 GBp
Earnings Per Share: 0.68 GBp
P/E Ratio: 36.95
Exchange: LSE
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 18421
Market Capitalization: 4.0 billion
Average Dividend Frequency: 2
Years Paying Dividends: 19
DGR3: -5.62%
DGR5: 19.58%
DGR10: 30.00%